Prosecution Insights
Last updated: August 18, 2026

Examiner: LIN, JERRY

Tech Center 1600 • Art Units: 1631 1671 1684 1685

This examiner grants 72% of resolved cases

Performance Statistics

72.3%
Allow Rate
+12.3% vs TC avg
855
Total Applications
+15.0%
Interview Lift
1426
Avg Prosecution Days
Based on 837 resolved cases, 2023–2026

Rejection Statute Breakdown

33.4%
§101 Eligibility
14.5%
§102 Novelty
20.6%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19287202 MULTIPLE-TIERED SCREENING AND DIAGNOSTIC ANALYSIS Non-Final OA Flagship Pioneering Innovations VI, LLC
18185105 VALIDATION OF INFERRED ANTICANCER PATHWAYS Non-Final OA Nant Holdings IP, LLC
18065014 INFUSION MANAGEMENT PLATFORM WITH INFUSION DATA GROUPING LOGIC Non-Final OA CAREFUSION 303, INC.
18265479 METHOD AND SYSTEM FOR SIMULTANEOUS INTERPRETATION OF TAXONOMIC DISTRIBUTION AND REPLICATION RATES OF MICROBIAL COMMUNITIES Non-Final OA Tata Consultancy Services Limited
18215789 METHODS AND SYSTEMS FOR GENERATING REGULATORY ELEMENTS Non-Final OA MONSANTO TECHNOLOGY LLC
16946215 SPARSE CO-VARYING UNIT OF THE HUMAN GUT MICROBIOTA THAT DESCRIBES HEALTHY AND IMPAIRED COMMUNITY DEVELOPMENT Non-Final OA WASHINGTON UNIVERSITY
17932712 SYSTEMS AND METHODS FOR IDENTIFYING SOMATIC MUTATIONS Final Rejection LIFE TECHNOLOGIES CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month